ERDAFITINIB | ERDAFITINIB | ATC L01EX16
ANTINEOPLASTIC FGFR1, FGFR2, FGFR3 AND FGFR4 KINASE INHIBITOR TREATMENT OF ADVANCED OR METASTATIC UROTHELIAL CARCINOMA ALSO BINDS TO RET, CSF1R, PDGFRA, PDGFRB, FLT4, KIT AND VEGFR2 | ORAL | Cmax 3.1 MICROMOLAR Tmax 2.5 HOUR VD 29 LITER PPB 99.8 PERCENT Cl 0.362 LITER / HOUR HT 59 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | FGFR1 FGFR2 FGFR3 FGFR4 PDB 5EW8 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH JNJ-4275693) LIGAND CODE = 5SF (link to the list of PDB complexes) Download experimental 3D coordinates of 5SF with added hydrogens | Fibroblast growth factor receptor 1 P11362 (FGFR1_HUMAN) | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |